RDY

NYSE Dr. Reddy's Laboratories Ltd. Sponsored ADR

Nov 3, 2026 · 1:12 PM ET DELAYED Market Open

$14.39 ↑ +0.25 (+1.80%) Trading Up from the previous close of $14.13, $0.04 below the day’s high of $14.42

YTD change: +2.46%
vs 20-day SMA: +9.07%
vs 200-day SMA: +8.81%

Price ranges

Previous day

$14.05 $14.20

open $14.15 close $14.13

-$0.02 (-0.14%)

Today

$14.23 $14.42

open $14.26 now $14.39

+$0.13 (+0.88%)

Past week

$13.62 $14.33

from $13.75 now $14.39

+$0.64 (+4.62%)

Past month

$11.99 $14.33

from $12.32 now $14.39

+$2.07 (+16.76%)

This year

$11.36 $15.67

from $14.04 now $14.39

+$0.35 (+2.46%)

Price & Performance

+0.78 (+5.84%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good

The stock is 14.8% away from all-time highs of $16.89
RDY is up 2% since the beginning of the year
RDY is up 7% over the past 12 months
RDY is up 17% over the past 1 month
3% of all RDY investors are betting against RDY
Number of investors short RDY has gone down 8% versus last month

RDY reads very good: price sits above both the 20- and 200-day averages, short interest is falling month over month, the 12-month move is +5.4%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes

EPS $0.116606

Earnings momentum +6.8% Quarterly EPS growth

Quarterly change +6.8%

Valuation

P/E ratio 40.49

Enterprise value $11.8B

Beta 0.04

Balance sheet & scale

Income$296.2K

Revenue$3.5B

Cash$795.6M

Debt$754.3K

Income / Debt 0.39×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE

Sector Manufacturing

Sub Sector Chemical Manufacturing

Market cap $12.0B

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services and Active Ingredients, and Others. The Global Generics segment refers to the manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services and Active Ingredients segment focuses on manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

Competitor comparison

Ticker	Company	Price	Change
LLY	Eli Lilly and Company	$1,410.99	-0.46%
JNJ	Johnson & Johnson	$270.56	-0.97%
ABBV	AbbVie, Inc.	$288.84	-2.05%
MRK	Merck & Co., Inc.	$148.36	-0.78%
RHHBY	Roche Holding Ltd Sponsored ADR	$60.67	-0.98%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.